Huntsville Holistics

02/01/2026

🌿Fasting reduces side effects and increases efficacy of conventional cancer therapy: chemotherapy, radiation, surgery.🌿

Metabolic shifts during fasting — including lower glucose and insulin levels and activation of cellular repair pathways — makes cancer cells more vulnerable and support treatment effectiveness while protecting normal cells through mechanisms like autophagy and stress resistance pathways.

Here’s what science demonstrates:

🔥 Benefits
• Fasting reduces insulin and growth-factor signals that support cancer cells.
• Fasting lowers markers of DNA damage and reduces neutropenia and neuropathy
• Fasting enhances immune responses and therapeutic sensitivity to chemotherapy or radiation

💡 Important Note
Fasting during cancer treatment should not be done alone. Safety varies by cancer type, treatment plan, nutrition status, and individual medical history.
________________________________________
🌱 Supporting Your Journey with Evidence-Based Guidance

✨ My Fasting Coaching Program
I guide my clients through safe, personalized fasting protocols tailored to their treatment schedules, goals, and energy needs — with a focus on minimizing risks and supporting resilience.

✨ My Survivor to Thriver Roadmap
This holistic program integrates nutritional strategies, therapeutic fasting, detox pathways, metabolic support, and mindful lifestyle interventions to help you move from surviving cancer treatment to thriver status.

It’s not just about reducing side effects — it’s about building lasting strength and quality of life.
________________________________________
Let’s talk about safe timing, medically appropriate approaches, and how it fits into your overall therapy plan.

📩 DM me or comment below if you're ready to stop surviving and start thriving!

🤝 You Deserve Support That Matches the Science

Emerging evidence suggests that fasting could play a key role in cancer treatment by fostering conditions that limit cancer cells' adaptability, survival, and growth. Fasting could increase the effectiveness of cancer treatments and limit adverse events. Yet, we lack an integrated mechanistic model....

01/09/2026

It’s simple.
Eat real food. Not too much. Mostly plants.

12/30/2025

✨ Lunch & Learn: Supplements—What’s Worth It & What’s Not ✨

There’s a LOT of information (and marketing!) out there when it comes to supplements — and it can be confusing to know what your body actually needs versus what’s just expensive hype.

Join us and learn from the experts at our monthly Lunch & Learn.

We’ll talk about:
• Which supplements are truly necessary
• Which ones are often not needed
• Food-based alternatives to supplements
• How to choose trusted, high-quality brands
• How and when to take supplements for best absorption
• How to avoid wasting money while still supporting your health

Space is limited. RSVP to secure your spot!
https://www.muskokamarketeatery.com/lunchandlearn

📅 Date: January 3, 2026
⏰ Time: 11am
📍 Location Muskoka Market & Eatery - Food Cooperative

Bring your questions, and your curiosity 💙

12/10/2025

A recent study found that when women with breast cancer combined vitamin D with chemotherapy they had a “pathological complete response”(pCR) of 43%, versus women taking placebo had only 24% (p = 0.04). And a logistic regression found that women whose vit D levels were ≥20ng/mL were more likely to achieve pCR (OR 3.65, p = 0.04) - that is, they were 3.65 times more likely to have a pCR.

Importantly, both the vitamin D and the placebo group had vitamin D deficiency at the start of the trial.

https://pubmed.ncbi.nlm.nih.gov/40098326/?fbclid=IwRlRTSAOmVDJleHRuA2FlbQIxMQBzcnRjBmFwcF9pZAo2NjI4NTY4Mzc5AAEebMjDuwEUoAyohiXiJ_GR6tA9cyPAS6UUq8soSGjleOZU9ruECZObQweN_5c_aem_tfkRYFixVVVq7A5d9NjZpQ

Ensaiosclinicos.gov.br, identifier RBR-10k4gqdg.

11/06/2025

Melatonin, known as the sleep hormone but its benefits don’t stop there.

Melatonin has impressive efficacy and safety for the prevention and treatment of cancers.”

I take 25-30mg every night to support detoxification, immune system, and cellular clean up.



#

https://doi.org/10.18632/oncotarget.16379 Ya Li, Sha Li, Yue Zhou, Xiao Meng, Jiao-Jiao Zhang, Dong-Ping Xu, Hua-Bin Li

10/31/2025

Yep!

10/25/2025

Knowledge is power!

Just in time for cold and flu season, learn the tools to strengthen your immune system and your resiliency.

10/24/2025

Cancer accounts for one in seven deaths worldwide and is the second leading cause of death in the United States, after heart disease. One of the standard cancer treatments is chemotherapy which sometimes can lead to chemoresistance and treatment failure. Therefore, there is a great need for novel th...

10/22/2025

#

10/18/2025

In light of October being breast cancer awareness month, here is what happens when you play an ACTIVE role in your cancer journey.

10/02/2025

Stubborn belly fat? Low energy? High blood pressure? High cholesterol? Joint pain? Diabetes? Heart disease? Cancer?

Lunch & Learn: Therapeutic Fasting & How To Do It Right

🏫Muskoka Market & Eatery - Food Cooperative
🕙Saturday, October 4th 11am
💲Free

09/27/2025

Artemisinin is an effective anti malarial TCM herb, that also has potent anti cancer properties. Artesunate (ART) is the semisynthetic derivative of artemisinin. ART has a better absorption than its natural counterpart artemisinin. This study demonstrates ART anti cancer effect on prostate cancer, but artemisinin and ART also effective for other cancers including breast, ovarian, gastric, and melanomas.

From the study:
"Recent studies have shown that ART acts on the electron transport chain (of cancer) and is directly involved in reactive oxygen species generation, which leads to mitochondrial membrane depolarization and an apoptosis response cascade.
In summary, our study is the first demonstration that lncRNA participates in the antitumor effect of ART. ART significantly inhibited the viability and mobility of PCa cell lines triggered by UCA1 down-regulation. All the described clinical data support the proposition that over-expression of UCA1 may play a key role in PCa progression and development."
https://www.oncotarget.com/article/15353/text/

https://doi.org/10.18632/oncotarget.15353 Yan Zhou, Xiuju Wang, Jianjun Zhang, Aina He, Ya Ling Wang, Kun Han, Yang Su, Junyi Yin, Xiaobin Lv, Haiyan Hu